Stryker Co. (NYSE:SYK) is Stokes Capital Advisors LLC’s 5th Largest Position

Stokes Capital Advisors LLC lifted its stake in shares of Stryker Co. (NYSE:SYK) by 1.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,388 shares of the medical technology company’s stock after purchasing an additional 261 shares during the quarter. Stryker comprises approximately 2.7% of Stokes Capital Advisors LLC’s portfolio, making the stock its 5th biggest position. Stokes Capital Advisors LLC’s holdings in Stryker were worth $9,443,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of SYK. Carnegie Capital Asset Management LLC raised its position in Stryker by 0.5% in the fourth quarter. Carnegie Capital Asset Management LLC now owns 96,241 shares of the medical technology company’s stock worth $28,820,000 after acquiring an additional 497 shares in the last quarter. Atlantic Edge Private Wealth Management LLC purchased a new position in Stryker in the fourth quarter worth $1,561,000. CoreCap Advisors LLC raised its position in Stryker by 3.9% in the fourth quarter. CoreCap Advisors LLC now owns 5,030 shares of the medical technology company’s stock worth $1,506,000 after acquiring an additional 191 shares in the last quarter. Consolidated Planning Corp purchased a new position in Stryker in the fourth quarter worth $205,000. Finally, Meritage Portfolio Management acquired a new stake in Stryker in the fourth quarter valued at $569,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

SYK has been the topic of several research reports. BTIG Research upped their target price on Stryker from $366.00 to $369.00 and gave the company a “buy” rating in a report on Wednesday, May 1st. Evercore ISI upped their target price on Stryker from $340.00 to $370.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. Needham & Company LLC raised Stryker from a “hold” rating to a “buy” rating and set a $392.00 target price on the stock in a report on Wednesday, May 22nd. TD Cowen upped their target price on Stryker from $365.00 to $400.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Finally, UBS Group upped their target price on Stryker from $339.00 to $351.00 and gave the company a “neutral” rating in a report on Wednesday, May 1st. Four analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and an average target price of $370.58.

Stryker Trading Down 0.2 %

Shares of Stryker stock traded down $0.62 during trading hours on Friday, reaching $339.92. The stock had a trading volume of 172,795 shares, compared to its average volume of 1,301,811. The firm has a 50 day simple moving average of $336.82 and a two-hundred day simple moving average of $333.01. The firm has a market capitalization of $129.49 billion, a price-to-earnings ratio of 38.87, a P/E/G ratio of 2.68 and a beta of 0.92. The company has a current ratio of 1.71, a quick ratio of 0.99 and a debt-to-equity ratio of 0.56. Stryker Co. has a 1 year low of $249.98 and a 1 year high of $361.41.

Stryker (NYSE:SYK) last released its quarterly earnings data on Tuesday, April 30th. The medical technology company reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.36 by $0.14. The company had revenue of $5.24 billion for the quarter, compared to the consensus estimate of $5.10 billion. Stryker had a return on equity of 23.05% and a net margin of 16.03%. The company’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same period last year, the business posted $2.14 EPS. As a group, equities research analysts anticipate that Stryker Co. will post 11.95 earnings per share for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be issued a $0.80 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.94%. Stryker’s dividend payout ratio (DPR) is 36.53%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.